Article
Pharmacogenetics may explain part of the interindividual variability of dobutamine pharmacodynamics in neonates.
British journal of clinical pharmacology - 1 Sept 2022
Hallik Maarja, Soeorg Hiie, Kahre Tiina, Murumets Ülle, Ilmoja Mari-Liis, Kipper Karin, Metsvaht Tuuli
Abstract excerpt
AIMS: To determine whether the known single nucleotide polymorphisms in adrenoreceptor associated genes affect the haemodynamic response to dobutamine in critically ill neonates. METHODS: Alleles in the known genetic single nucleotide polymorphisms in β1- and β2-adrenoceptor (AR) genes and Gs protein α-subunit gene (GNAS) possibly affecting inotropic effect were identified in patients of neonatal dobutamine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
